Intelektas LT+

2014 07 15

Success of UAB "Profarma" in implementation of the project “Expansion of infrastructure of UAB Profarma dedicated to R&D and technological investigations“

UAB "Profarma" has successfully executed the project VP2-1.3-ŪM-03-K-03-055 “Expansion of infrastructure of UAB Profarma dedicated for R&D and technological investigations“. The project was mutually supported by European Regional Development Fund under the measure "Intelektas LT+“, Nr. VP2-1.3-ŪM-03-K and private investments of the company with the total value of 3,4 mln. Lt. During the execution period the infrastructure of UAB Profarma has been expanded installing the lab equipment dedicated for the development of patented ProMer, technology to create biobetter pharmaceuticals with improved therapeutic values. Implementation of the project allowed to expand the area of the investigations and created few new workplaces. Using the new capabilities scientists of the company expanded the portfolio of the products developed on the basis of ProMer™ technology creating the innovative product with neuroprotective action dedicated for the treatment of ophthalmic diseases. The previous project of the company of the gynecology product line ProBV™ directed for the treatment and prophylaxis of bacterial vaginosis has been finished in the new labs of “Profarma”. The newly established infrastructure allowed to expand turnover of the company more than 15 times during 2013, and it is expected that in 2014 the turnover will reach 1,8 mln. Lt.

Back to news

Contacts
JSC "PROFARMA"


V.A. Graiciuno 6, LT-02241,
Vilnius, Lithuania


Tel. +370 5 2629761,
E-mail: info@profarma.lt